山茶花精油
Search documents
这条羊绒蚕丝裤太变态!轻盈显瘦还不冻腿,冬天穿太舒服了
凤凰网财经· 2025-11-17 13:06
天冷了真得注意保暖。以前想着年轻抗冻,大冷天的还光着腿,现在天稍有凉意就腿疼。 所以一有变冷的征兆,我都会赶紧提前给自己准备一条好穿又保暖的裤子。 特别是上了年纪后, 身体循环变慢, 寒气更容易侵入,未雨绸缪 趁早保护膝腿是要紧事! 不过 秋冬季选裤子可太考验水平了,因为 : 厚≠暖和! 裤子暖不暖是在于面料能不能形成一个蓬松的中空保温层,从而圈住热量。 如果厚但是太紧且不透气的话, 你只会觉得又闷又难受,还不觉得有多暖。 难道就没有一条轻盈贴身又保暖的打底裤吗? 有! 今年我就发现了 对抗寒冷的正确打开方式—— 一条舒服保暖的羊绒裤 它真的是"人间小火炉"! 蚕丝倒是使得裤子更加柔软亲肤~ 都说寒从脚起,穿上这条裤子,能同时 扛住北方的寒风和南方的湿气 ,你就是这个冬天的超强王者! 它还兼具一条秋冬保暖打底裤该有的必备因素: 显瘦、不掉档、不勒腿 ! 要不是我说,同事压根不知道我里面穿了打底裤。 兼顾保暖又不显胖,一举两得!赢麻了! 冬天即使穿条长裙也不再惧怕寒冷~ 有了它不但白天可以少穿点,晚上睡觉躺在被窝里也能暖得更快。 双面磨毛+软黄金"羊毛"+ 蚕丝,一条就能抵3条普通秋裤! 两面的 薄绒自带暖绒绒 ...
护肤行业的“功效叙事”,隐忧渐显
Hu Xiu· 2025-07-10 02:09
Core Insights - The skincare industry is experiencing intense competition in technology, with numerous suppliers showcasing unique ingredients and certifications at a recent cosmetics trade show [1][2][3] - The trend of emphasizing active ingredients and technical claims on product packaging is prevalent, as brands seek to carve out market positions by replicating successful commercial models [4][5] - The lack of authoritative industry standards and clarity on ingredient efficacy is causing confusion and skepticism among consumers [6][7][8] Group 1: Active Ingredients and Technology Trends - Active proteins and plant extracts remain core competitive areas in the skincare industry, with leading brands continuing to invest heavily in research and development [10][11] - The popularity of active proteins is driven by their previous applications in medical and aesthetic fields, which lend credibility to their use in consumer products [15][20] - New technologies in plant extraction are emerging, aiming to address traditional challenges such as stability and absorption rates [18][19] Group 2: Marketing and Industry Challenges - The rapid iteration of core ingredients in domestic beauty brands has outpaced normal industry evolution, leading to communication gaps between technology, products, and consumers [22][23] - The absence of unified national standards for new ingredients has resulted in market confusion and potential harm to consumers [24][26] - Overemphasis on marketing claims has led to exaggerated efficacy narratives, causing consumer dissatisfaction and adverse reactions [30][31][33] Group 3: Future Directions and Brand Strategies - The skincare industry is entering a period of deep adjustment, with competition shifting from ingredient-based to ecosystem-building capabilities [37][39] - Brands must find new competitive advantages beyond ingredient efficacy, such as emotional value and consumer experience [41][42] - The rise of niche markets, including male skincare and elderly care, presents new opportunities for growth and diversification [48][49]
林清轩IPO:2022年曾陷亏损、靠小样狂潮堆砌“假高端”?三年研发投入不足亿元却用近6成收入做营销
Xin Lang Zheng Quan· 2025-06-18 09:12
Core Viewpoint - The article discusses the recent surge in stock prices of new consumption companies in Hong Kong, particularly highlighting the IPO of Lin Qingxuan and the challenges it may face in achieving stable profitability and brand reliance [1][2]. Financial Performance - Lin Qingxuan's revenue has shown growth from 6.91 billion RMB in 2022 to 12.10 billion RMB in 2024, with year-on-year growth rates of 16.5% in 2023 and 50.3% in 2024 [3]. - The company reported a net loss of 5.93 million RMB in 2022, but turned a profit of 84.52 million RMB in 2023 and 187 million RMB in 2024 [3]. Profitability Metrics - The gross profit margin for Lin Qingxuan was high, with figures of 78%, 81.2%, and 82.5% from 2022 to 2024, while the net profit margin improved from -0.9% in 2022 to 15.4% in 2024 [5]. - The company heavily promotes its "high-end" branding, which is a central theme in its IPO prospectus, mentioned 157 times [5]. Marketing and R&D Expenditure - Lin Qingxuan's marketing expenses are significant, with sales and distribution costs amounting to 5.09 billion RMB, 4.86 billion RMB, and 6.88 billion RMB from 2022 to 2024, representing 73.7%, 60.2%, and 56.9% of total revenue respectively [12][13]. - In contrast, R&D spending was low, totaling less than 100 million RMB over three years, with only 80 patents held, of which 42 are related to core ingredients or technologies [13]. Brand and Product Dependency - The company relies heavily on its single brand "Lin Qingxuan," which accounted for 99% of total revenue from 2022 to 2024, raising concerns about its vulnerability to market changes [11]. - The core product, camellia oil, has increased its revenue contribution from 31.5% in 2022 to 37% in 2024, indicating a growing dependency on this single product line [12].